Childhood cancer survivors over age 50 had a threefold higher mortality risk compared with the general population, primarily ...

1. You may have problems with your prostate that aren’t cancer.

BLRX READ THE FULL BLRX RESEARCH REPORT BioLineRx Ltd. (NASDAQ:BLRX) reported second quarter 2025 results, producing license revenues of $304,000. Following the transition of commercialization ...

New clinical data reveals promising efficacy of VS-7375, a KRAS G12D inhibitor, in advanced lung cancer, highlighting its ...

Q2 2025 Earnings Call Transcript August 14, 2025 BioLineRx Ltd. misses on earnings expectations. Reported EPS is $-1 EPS, ...

Nationally recognized leader in cancer control interventions to strengthen community outreach and advance cancer care at TGH Cancer Institute.

IO Biotech plans to meet with the FDA this fall to discuss the data from the phase 3 trial of Cylembio and determine next ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, has announced its ...

Study reveals one-third of mantle cell lymphoma patients in a study at leading cancer centers experienced disease progression ...

Local cancer patients find hope through community support and medical advances, with stories of resilience from an Aces dancer battling ovarian cancer and a mother benefiting from biomarker testing.

Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical ...

Stacker ranked the 50 highest-paying jobs in America using wage estimates from the Bureau of Labor Statistics, which were ...